Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 8,522 | 11,463 | 8,283 | 11,065 | 6,834 |
| Operating Income | -8,522 | -11,463 | -8,283 | -11,065 | -6,834 |
| Other Income | 206 | 219 | 137 | 164 | 123 |
| Pre-tax Income | -8,316 | -11,244 | -8,146 | -10,901 | -6,711 |
| Net Income Continuous | -8,316 | -11,244 | -8,146 | -10,901 | -6,711 |
| Net Income | $-8,316 | $-11,244 | $-8,146 | $-10,901 | $-6,711 |
| EPS Basic Total Ops | -7.20 | -9.60 | -9.20 | -12.60 | -7.80 |
| EPS Basic Continuous Ops | -7.10 | -9.49 | -9.21 | -12.67 | -7.80 |
| EPS Diluted Total Ops | -7.20 | -9.60 | -9.20 | -12.60 | -7.80 |
| EPS Diluted Continuous Ops | -7.10 | -9.49 | -9.21 | -12.67 | -7.80 |
| EBITDA(a) | $-8,522 | $-11,463 | $-8,283 | $-11,065 | $-6,834 |